# Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury

> **NCT02923817** · PHASE2 · UNKNOWN · sponsor: **Da Nang Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **BIOLOGICAL:** Transplantation of autologous bone marrow-derived mononuclear cells by lumbar injection

## Key facts

- **NCT ID:** NCT02923817
- **Lead sponsor:** Da Nang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923817, "Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02923817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*